CHIR-265   Click here for help

GtoPdb Ligand ID: 5674

Synonyms: CHIR 265 | CHIR265 | RAF 265 | RAF-265 | RAF265
PDB Ligand
Compound class: Synthetic organic
Comment: CHIR-265 is an orally bioavailable inhibitor of RAF kinases, including the BRAF V600E mutant. It also inhibits phosphorylation of VEGFR2 [3] (link to this abstract at AACR Meeting Abstracts Online #4876).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 80.65
Molecular weight 518.13
XLogP 5.71
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cn1c(Nc2ccc(cc2)C(F)(F)F)nc2c1ccc(c2)Oc1ccnc(c1)c1[nH]cc(n1)C(F)(F)F
Isomeric SMILES Cn1c(Nc2ccc(cc2)C(F)(F)F)nc2c1ccc(c2)Oc1ccnc(c1)c1[nH]cc(n1)C(F)(F)F
InChI InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)
InChI Key YABJJWZLRMPFSI-UHFFFAOYSA-N
Bioactivity Comments
In biochemical assays, CHIR-265 (as RAF265) inhibits B-RafV600E, B-Raf, c-Raf, VEGFR2, c-Kit, PDGFRβ with IC50s <100 nM [3]. In vivo, RAF265 inhibits tumour volume by >70% in HCT116 (human colon carcinoma cell) xenografts at 12 mg/kg [2].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
B-Raf proto-oncogene, serine/threonine kinase Primary target of this compound Hs Inhibitor Inhibition 5.9 pKd - 1
pKd 5.9 (Kd 1.2x10-6 M) [1]